New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2013
12:00 EDTTROVTrovagene falls 18.9%
Trovagene is down 18.9%, or $1.23, to $5.28
News For TROV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 1, 2016
05:31 EDTTROVTrovagene enters agreement with FedMed
Trovagene announced that it has entered into an agreement with FedMed establishing health benefit access to Trovagene's full line of Precision Cancer Monitoring, or PCM, tests and services. Under the agreement, Trovagene's PCM services are covered as a participating laboratory testing provider for clients of FedMed, which include major health insurers such as Aetna, Cigna and Humana, and encompasses over 550,000 in-network physicians nationwide.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use